This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: University of Miami. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hollywood, FL (US) (2013 - 2016)
- Miami, FL (US) (2017)
Company Filing History:
Years Active: 2013-2017
Title: Joseph David Rosenblatt: Innovator in Cancer Treatment
Introduction
Joseph David Rosenblatt is a prominent inventor based in Miami, FL (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of fusion proteins. With a total of 5 patents, Rosenblatt's work focuses on advancing therapeutic methods for combating tumors and autoimmune diseases.
Latest Patents
Rosenblatt's latest patents include groundbreaking inventions such as the "Antibody-endostatin fusion protein and its variants." This patent outlines methods for inhibiting tumor growth by administering chimeric fusion molecules that comprise endostatin mutants along with anti-Her2 or anti-EGFR antibodies. Another notable patent is titled "Compositions, methods and kits for treatment of cancer and autoimmune diseases." This invention is directed towards fusion proteins that combine an IL-21 cytokine portion with an anti-CD20 antibody portion, providing methods for utilizing these fusion proteins in therapeutic applications.
Career Highlights
Joseph David Rosenblatt is affiliated with the University of Miami, where he continues to engage in cutting-edge research. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from cancer and autoimmune disorders.
Collaborations
Rosenblatt has collaborated with esteemed colleagues such as Eckhard R Podack and Koichi Yamazaki, contributing to a rich environment of innovation and discovery in the field of medical research.
Conclusion
Joseph David Rosenblatt stands out as a key figure in the development of novel cancer therapies. His innovative patents and collaborative efforts reflect his commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile